Augmentation of RBP4/STRA6 signaling leads to insulin resistance and inflammation and the plausible therapeutic role of vildagliptin and metformin Post date July 19, 2024 ← Determine the Arrest Factors in Survival Outcome of Patients with IHCA → Glycogen synthase kinase3β: A key player of cognitive dysfunction in chronic kidney disease patients and a possible link between abnormal pTau and platelet APP processing and therapeutic role of erythropoietin